This is a permanent results page for your analyzed data. Please save the link in your browser's address bar.
| Title / Description | TRAIL and taurolidine enhance the anticancer activity of doxorubicin, trabectedin and mafosfamide in human fibrosarcoma cells. |
| Accession | GSE32441 |
| Summary | Microarray analysis revealed differential gene expression patterns of HT1080 cells treated with various chemical compounds alone and in combination (trabectedin, doxorubicin, mafosfamide, TRAIL, taurolidine) |
| Organism | Homo sapiens |
| Platform | GPL4133 |
| Normalized | True |
| Parsed SOFT file |
| Differential expression method | Characteristic Direction |
| Cutoff | 500 |
| Cell | Fibrosarcomas |
| Perturbation | Trabectedin |
| Disease | Oncology |
| Principal Component Analysis | |
| Hierarchical clustering |
| Gene lists | Enrichr | L1000CDS2 | PAEA | |
| Up |
|
|||
| Down |
|
|||
| Combined |
|
|
|
